KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Supernus Pharmaceuticals (SUPN) Shares Issued: 2011-2025

Historic Shares Issued for Supernus Pharmaceuticals (SUPN) over the last 13 years, with Sep 2025 value amounting to $23.7 million.

  • Supernus Pharmaceuticals' Shares Issued rose 585.76% to $23.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.9 million, marking a year-over-year increase of 293.91%. This contributed to the annual value of $14.9 million for FY2024, which is 125.54% up from last year.
  • As of Q3 2025, Supernus Pharmaceuticals' Shares Issued stood at $23.7 million, which was up 624.69% from $3.3 million recorded in Q2 2025.
  • Supernus Pharmaceuticals' 5-year Shares Issued high stood at $23.7 million for Q3 2025, and its period low was $524,000 during Q3 2021.
  • For the 3-year period, Supernus Pharmaceuticals' Shares Issued averaged around $4.6 million, with its median value being $2.5 million (2023).
  • As far as peak fluctuations go, Supernus Pharmaceuticals' Shares Issued spiked by 6,921.88% in 2021, and later tumbled by 88.54% in 2023.
  • Quarterly analysis of 5 years shows Supernus Pharmaceuticals' Shares Issued stood at $1.6 million in 2021, then skyrocketed by 79.62% to $2.8 million in 2022, then plummeted by 61.40% to $1.1 million in 2023, then skyrocketed by 529.76% to $6.9 million in 2024, then spiked by 585.76% to $23.7 million in 2025.
  • Its Shares Issued was $23.7 million in Q3 2025, compared to $3.3 million in Q2 2025 and $2.0 million in Q1 2025.